1)Yasuda S, Ide M, Fujii H, et al. Application of positron emission tomography imaging to cancer screening. Br J Cancer 83:1607-1611, 2000
2)Sengoku T, Matsumura K, Usami M, et al. Diagnostic accuracy of FDG-PET cancer screening in asymptomatic individuals:use of record linkage from the Osaka Cancer Registry. Int J Clin Oncol 19:989-997, 2014
3)Lindholm E, Brevinge H, Haglind E. Survival benefit in a randomized clinical trial of fecal occult blood screening for colorectal cancer. Br J Surg 95:1029-1036, 2008
4)Minamimoto R, Senda M, Jinnouchi S, et al. The current status of an FDG-PET cancer screening program in Japan, based on a 4-year(2006-2009)nationwide survey. Ann Nucl Med 27:46-57, 2013
5)Telford J, Gentile L, Gondara L, et al. Performance of a quantitative fecal immunochemical test in a colorectal cancer screening pilot program:a prospective cohort study. CMAJ Open 4:E668-673, 2016
6)Sekiguchi M, Kakugawa Y, Terauchi T, et al. Sensitivity of 2-[18F]fluoro-2-deoxyglucose positron emission tomography for advanced colorectal neoplasms:a large-scale analysis of 7505 asymptomatic screening individuals. J Gastroenterol 51:1122-1132, 2016
7)Huang SW, Hsu CM, Jeng WJ, et al. A comparison of positron emission tomography and colonoscopy for the detection of advanced colorectal neoplasms in subjects undergoing a health check-up. PLoS One 8:e69111
8)Hirakawa T, Kato J, Okumura Y, et al. Detectability of colorectal neoplasia with fluorine-18-2-fluoro-2-deoxy-D-glucose positron emission tomography and computed tomography(FDG-PET/CT). J Gastroenterol 47:127-135, 2012
9)van Kouwen MC, Nagengast FM, Jansen JB, et al. 2-(18F)- fluoro- 2-deoxy-D-glucose positron emission tomography detects clinical relevant adenomas of the colon:a prospective study. J Clin Oncol 23:3713-3717, 2005
10)Arslan N, Dehdashti F, Siegel BA. FDG uptake in colonic villous adenomas Ann Nucl Med 19:331-334, 2005